SharePoint
Aide
Faire avancer la sûreté nucléaire

La Recherchev2

Publications

Transplantation of stromal cells transduced with the human IL3 gene to stimulate hematopoiesis in human fetal bone grafts in non-obese, diabetic-severe combined immunodeficiency mice


Fermer

Authentification

Email :

Mot de passe :

Brouard N, Chapel A, Neildez-Nguyen TM, Granotier C, Khazaal I, Peault B, Thierry D, Leukemia 1998 Jul;12(7):1128-35

Type de document > *Article de revue

Mots clés > radioprotection, radiohématologie, cytokine, interleukine

Unité de recherche > Laboratoire de recherche en thérapeutiques des irradiations_(LRTI)

Auteurs > CHAPEL Alain, THIERRY Dominique

Date de publication > 01/01/1998

Résumé

The non-obese diabetic-severe combined immunodeficiency (NOD-SCID) mouse is a convenient host for human hematopoietic tissues and cells. Human fetal bone fragments engrafted subcutaneously in NOD-SCID mice sustain human hematopoiesis for several months. MS5 murine bone marrow stromal cells were transfected by electroporation with a plasmid containing the human interleukin-3 gene. As expected, stably transfected hu-IL3-MS5 cells supported human hematopoiesis in vitro more efficiently than MS5 cells. hu-IL3-MS5 cells were then injected intravenously into hu-NOD-SCID mice to test their ability to home to the mouse and/or human bone marrow, and to evaluate the role of hu-IL3 secretion on human hematopoiesis in vivo. hu-IL3 was detected in the mouse serum for up to an observation time of 8 weeks. hu-IL3-MS5 cells engrafted the bone marrow, spleen, liver and lungs of the mice but also the human bone graft. The presence of hu-IL3-MS5 cells in the human bone significantly stimulated local human hematopoiesis. This setting could be used to model the bone marrow homing of intravenously injected stromal cells or stromal cell precursors. The same experimental principle could also be applied in a therapeutic perspective to malignant human bone marrow hematopoiesis.